CTOs on the Move

CardioDX

www.cardiodx.com

 
The mission of Crescendo Bioscience, Inc. is to enable more effective management of autoimmune and inflammatory diseases by providing quantitative, objective molecular tests and disease information services to rheumatologists and patients. Crescendo Bioscience is currently focused on rheumatoid arthritis (RA), a debilitating, chronic disease affecting over 1.5 million people in the United States and more than 2 million in Europe. Although there is no known cure for RA, multiple therapies are available, with widely differing levels of effectiveness and significant potential toxicities. Choosing the optimal treatment from among these therapeutic alternatives is a tremendous challenge. At Crescendo Bioscience, we are ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cardiodx.com
  • 600 Saginaw Drive
    Redwood City, CA USA 94063
  • Phone: 650.475.2788

Executives

Name Title Contact Details

Similar Companies

HealthCheckUSA / EmployeeWellnessUSA

HealthCheckUSA / EmployeeWellnessUSA is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

United WestLabs

United WestLabs, Inc. is a Santa Ana, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Agendia USA

Agendia is a precision oncology company headquartered in Irvine, California, committed to bringing patients with early stage breast cancer and their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence, that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines. BluePrint®, the 80-gene molecular subtyping assay, is the only commercially-available test that evaluates the underlying biology of a tumor to determine what is driving its growth. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help physicians make more informed decisions in the pre- and post-operative treatment settings. Agendia develops evidence-based novel genomic tests and forges partnerships with groundbreaking companies to develop next-generation digital treatment tools. The ongoing research builds an arsenal of data that improve patient outcomes and support the evolving clinical needs of patients with breast cancer and their physicians every step of the way, from initial diagnosis to cancer-free.

Bellevue Pharmacy

Bellevue Pharmacy is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

JEM 4

JEM 4 is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.